$MTZ

Csiszar Ernst N sold $2.4M of MTZ

Csiszar Ernst N sold 6,500 shares of MASTEC INC (MTZ) at $371.17 ($2.41M total) on 2026-06-03.

Original reporting
SEC EDGAR · Csiszar Ernst N
Published Jun 5, 2026, 8:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MTZ
Neutral
medium confidence
Mentioned
$MTZ
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MTZNeutralLow
01

Why it matters

The disclosure updates insider activity records; without additional corporate events, it mainly affects short-term sentiment rather than valuation drivers.

02

Market read

Traders may monitor for follow-on insider buys/sales or other catalysts, but this filing alone is unlikely to materially reprice the stock.

03

What to watch

Absence of a stated 10b5-1 plan could increase scrutiny, but the article provides no reason for the sale or any follow-on buy activity.

Relevance 6/10Novelty 6/10Timing: Filed June 5; sale occurred June 3 (latest insider activity update).

Background

The article is an SEC Form 4 insider transaction disclosure for MasTec, Inc. (MTZ).

Company-level read

Ticker impact

$MTZNeutralMedium confidence
Context

Director Csiszar Ernst N sold 6,500 MTZ shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless followed by additional disclosures.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan and no accompanying company-specific news (earnings, guidance, deal, litigation).

Market effects

No direct sector read-through; this is company-specific insider activity only.

None indicated.

None indicated.

Counterpoint

A single director sale can be planned for diversification or liquidity needs and may not reflect negative fundamentals.

Key entities

  • MasTec, Inc.

    Subject of the SEC Form 4 insider sale by a director.

  • Csiszar Ernst N

    Director who sold 6,500 shares of MTZ at $371.17/share.

Related articles

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.

$MTZMedAI 8/10

Does MasTec's Strong Q2 Justify Its Raised 2026 Outlook?

MasTec (MTZ) reported Q2 revenue up 23% to $4.37B, adjusted EBITDA up 40% to $384M, and adjusted EPS up 49% to $2.22, with 18-month backlog up 30% to a record $21.4B. Management raised 2026 guidance to $18.2B revenue, $1.6B EBITDA, and $9.30 EPS, citing strength in power, clean energy, and pipeline plus the Superior Group acquisition.

$MTZMed

MTZ Q2 Deep Dive: Communications Weakness Overshadowed by Power, Clean Energy, and Superior Group Acquisition

MasTec reported Q2 revenue of $4.37B, slightly above estimates, with adjusted EPS of $2.22 versus expectations. Management raised full-year adjusted EPS guidance to $9.30 and said backlog rose to $21.39B. Communications faced wireless and wireline timing delays, while power delivery and clean energy grew. MasTec also completed its largest acquisition, Superior Group.

$MTZMedAI 8/10

MasTec Q2 Earnings Call Highlights

MasTec (NYSE: MTZ) updated its outlook after its Q2 earnings call. Full-year revenue is now expected at $18.2B, adjusted EBITDA at $1.6B, and adjusted EPS at $9.30. Q3 revenue is forecast near $4.9B. Communications guidance was reduced to about $3.25B revenue, citing deferred projects and weaker wireless activity, while Power, Pipeline and Clean Energy targets were reiterated.

$MTZMedAI 8/10

Why MasTec (MTZ) Shares Are Sliding Today

MasTec (MTZ) shares fell 17.7% after its Q2 2026 results showed revenue of $4.37B, up 23.4% year over year, but adjusted EPS of $2.22 missed consensus of $2.23. The company raised full-year adjusted EPS guidance to $9.30 midpoint, below analyst expectations, driving the sell-off.